Related Experiment Video
Updated: Apr 17, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
Central venous catheter-related thrombosis
1Thromboembolism Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Insights
Central venous catheter (CVC) thrombosis causes significant patient harm and healthcare costs. Current prophylactic anticoagulation offers limited benefit, necessitating better strategies to prevent CVC-related blood clots.
Area of Science:
- Vascular Medicine
- Oncology
- Infectious Disease
Background:
- Central venous catheters (CVCs) are prone to thrombotic complications.
- These complications lead to patient symptoms, catheter dysfunction, infection risk, and increased healthcare costs.
- Risk factors include larger, multilumen, and peripherally inserted catheters, particularly in cancer patients undergoing chemotherapy.
Purpose of the Study:
- To review recent evidence on CVC-related thrombosis.
- To address remaining controversies in managing CVC thrombosis.
- To outline practical approaches for reducing the burden of CVC-associated thrombosis.
Main Methods:
- Review of recent clinical evidence and guidelines.
- Discussion of risk factors and current treatment strategies.
- Focus on practical management and prevention.
Main Results:
- Catheter-related thrombosis is a common and serious complication of CVC use.
- Anticoagulation is the primary treatment for symptomatic thrombosis, tailored to individual risk.
- Prophylactic anticoagulation has shown disappointing clinical benefits and is not routinely recommended.
Conclusions:
- Reducing the incidence and impact of CVC-related thrombosis requires a multifaceted approach.
- Further research is needed to optimize prevention and treatment strategies.
- Practical management should focus on risk assessment and appropriate anticoagulation intensity.
Abstract:
Thrombotic complications associated with the use of central venous catheters (CVCs) are common and lead to distressing patient symptoms, catheter dysfunction, increased risk of infections, long-term central venous stenosis, and considerable costs of care. Risk factors for catheter-related thrombosis include use of larger, multilumen, and peripherally inserted catheters in patients with cancer receiving chemotherapy. Symptomatic catheter-related thrombosis is treated with anticoagulation, generally without removing the catheter. The intensity and duration of anticoagulation depend on the extent of thrombosis, risk of bleeding, and need for continued use of a CVC. To date, the clinical benefit of prophylactic doses of anticoagulant has been disappointing and these agents are not used routinely for this purpose. This chapter focuses on recent evidence, remaining controversies, and practical approaches to reducing the burden of thrombosis associated with CVCs.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Continuous Renal Replacement Therapy
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...

